查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1888614

癌症恶病质市场规模、份额和趋势分析报告：按治疗方法、类型、分销管道、地区和细分市场预测（2025-2033 年）

Cancer Cachexia Market Size, Share & Trends Analysis Report By Treatment (Appetite Stimulants, Corticosteroids), By Type (Lung Cancer, Colorectal Cancer), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

癌症恶病质市场摘要

全球癌症恶病质市场预计在2024年达到25.4亿美元，预计到2033年将达到39亿美元，2025年至2033年的复合年增长率为4.86%。推动市场成长的因素包括癌症发病率上升、恶病质患者数量增加以及人们对恶病质的临床和经济影响的认识不断提高。

根据美国国立卫生研究院 (NIH) 2023 年 11 月发布的报告，癌症相关恶病质影响高达 74% 的癌症患者。它直接导致 20-30% 的癌症死亡，并在 22-30% 的病例中是主要死因。肿瘤学领域对支持性治疗的日益重视也推动了市场成长。同时，新兴市场医疗保健成本的上升和癌症治疗可近性的提高，也扩大了潜在客户群。随着全球癌症诊断和治疗患者数量的增加，对恶病质管理的需求也在增长，预计这将推动癌症恶病质产业的成长。

目录

第一章调查方法和范围

第二章执行摘要

第三章 癌症恶病质市场变数、趋势与范围

  • 市场谱系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 癌症恶病质市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析
  • 癌症恶病质市场：研发管线分析

第四章 癌症恶病质市场：治疗需求估算与趋势分析

  • 癌症恶病质市场：治疗方案差异分析
  • 全球癌症恶病质市场规模及趋势分析（依治疗方法划分，2021-2033 年）
    • 食慾刺激剂
    • 大麻素受体促效剂
    • 皮质类固醇
    • 合成代谢和男性化促效剂
    • 其他的

第五章 癌症恶病质市场：类型估算与趋势分析

  • 癌症恶病质市场：类型差异分析
  • 全球癌症恶病质市场规模及趋势分析（按类型划分，2021-2033 年）
    • 胰臟癌
    • 胃癌
    • 肺癌
    • 大肠直肠癌
    • 其他的

第六章：癌症恶病质市场：通路估算与趋势分析

  • 癌症恶病质市场：通路波动分析
  • 全球癌症恶病质市场规模及趋势分析（按分销管道划分，2021-2033 年）
    • 医院药房
    • 零售药房
    • 网路药房

第七章 癌症恶病质市场：区域估计与趋势分析

  • 区域市场概览
  • 区域市场占有率分析（2024 年和 2033 年）
  • 按地区分類的癌症恶病质市场：重点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 主要市场参与企业的最新发展及影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要企业热力图分析，2024 年
  • 公司简介
    • AbbVie Inc.
    • Endo, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Abbott.
    • Nestle Health Science
    • Baxter.
    • Fresenius Kabi AG
    • Sandoz Group AG
    • Bristol-Myers Squibb Company
Product Code: GVR-4-68040-788-5

Cancer Cachexia Market Summary

The global cancer cachexia market size was estimated at USD 2.54 billion in 2024 and is projected to reach USD 3.90 billion by 2033, growing at a CAGR of 4.86% from 2025 to 2033. The rising cancer incidence and more patients with cachexia, and growing recognition of cachexia's clinical & economic impact, drive the market.

According to a report published by NIH in November 2023, Cancer-related cachexia affects up to 74% of cancer patients. It is directly responsible for 20-30% of cancer deaths, making it the main cause of death in 22-30% of cases. The increasing focus on supportive care in oncology is also driving market growth. However, increasing healthcare spending and improving access to cancer care in emerging markets are helping expand the potential customer base. As more patients receive cancer diagnoses and treatment worldwide, the need for cachexia management grows, which is expected to drive the growth of the cancer cachexia industry.

Global Cancer Cachexia Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cancer cachexia market report based on treatment, type, distribution channel, and region:

  • Treatment Outlook (Revenue, USD Million, 2021 - 2033)
  • Appetite Stimulants
  • Cannabinoid Receptor Agonists
  • Corticosteroids
  • Anabolic/Androgenic Agents
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Pancreatic Cancer
  • Gastric (Stomach) Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Type
    • 1.2.3. Distribution channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment outlook
    • 2.2.2. Type outlook
    • 2.2.3. Distribution channel outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cancer Cachexia Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Cancer Cachexia Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Cancer Cachexia Market: Pipeline Analysis

Chapter 4. Cancer Cachexia Market: Treatment Estimates & Trend Analysis

  • 4.1. Treatment Segment Dashboard
  • 4.2. Cancer Cachexia Market: Treatment Movement Analysis
  • 4.3. Global Cancer Cachexia Market Size & Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
    • 4.3.1. Appetite stimulants
      • 4.3.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Cannabinoid receptor agonists
      • 4.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Corticosteroids
      • 4.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Anabolic/androgenic agents
      • 4.3.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cancer Cachexia Market: Type Estimates & Trend Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Cancer Cachexia Market: Type Movement Analysis
  • 5.3. Global Cancer Cachexia Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
    • 5.3.1. Pancreatic cancer
      • 5.3.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Gastric (stomach) cancer
      • 5.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Lung cancer
      • 5.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Colorectal cancer
      • 5.3.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Others
      • 5.3.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cancer Cachexia Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Distribution Channel Segment Dashboard
  • 6.2. Cancer Cachexia Market: Distribution Channel Movement Analysis
  • 6.3. Global Cancer Cachexia Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
    • 6.3.1. Hospital Pharmacies
      • 6.3.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Retail Pharmacies
      • 6.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Online Pharmacies
      • 6.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Cancer Cachexia Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2033
  • 7.3. Cancer Cachexia Market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Sweden
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework/ reimbursement structure
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. China
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. India
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework/ reimbursement structure
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company heat map analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. AbbVie Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Endo, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Teva Pharmaceutical Industries Ltd.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Pfizer Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Abbott.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Nestle Health Science
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Baxter.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Fresenius Kabi AG
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Sandoz Group AG
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Bristol-Myers Squibb Company
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 Global cancer cachexia market, by region, 2021 - 2033 (USD Million)
  • Table 2 Global cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 3 Global cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 4 Global cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 5 North America cancer cachexia market, by country, 2021 - 2033 (USD Million)
  • Table 6 North America cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 7 North America cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 8 North America cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 9 U.S. cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 10 U.S. cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 11 U.S. cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 12 Canada cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 13 Canada cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 14 Canada cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15 Mexico cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 16 Mexico cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 17 Mexico cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 Europe cancer cachexia market, by country, 2021 - 2033 (USD Million)
  • Table 19 Europe cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 20 Europe cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 21 Europe cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22 Germany cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 23 Germany cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 24 Germany cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 25 UK cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 26 UK cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 27 UK cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28 France cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 29 France cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 30 France cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 31 Italy cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 32 Italy cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 33 Italy cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34 Spain cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 35 Spain cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 36 Spain cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 37 Denmark cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 38 Denmark cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 39 Denmark cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 40 Sweden cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 41 Sweden cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 42 Sweden cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 43 Norway cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 44 Norway cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 45 Norway cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific cancer cachexia market, by country, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 50 China cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 51 China cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 52 China cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 53 Japan cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 54 Japan cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 55 Japan cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56 India cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 57 India cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 58 India cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 59 South Korea cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 60 South Korea cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 61 South Korea cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 62 Australia cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 63 Australia cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 64 Australia cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 65 Thailand cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 66 Thailand cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 67 Thailand cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 68 Latin America cancer cachexia market, by country, 2021 - 2033 (USD Million)
  • Table 69 Latin America cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 70 Latin America cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 71 Latin America cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 72 Brazil cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 73 Brazil cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 74 Brazil cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 75 Argentina cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 76 Argentina cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 77 Argentina cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 78 Middle East & Africa cancer cachexia market, by country, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 82 South Africa cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 83 South Africa cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 84 South Africa cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia midline carcinoma treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 88 UAE cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 89 UAE cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 90 UAE cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 91 Kuwait cancer cachexia market, by treatment, 2021 - 2033 (USD Million)
  • Table 92 Kuwait cancer cachexia market, by type, 2021 - 2033 (USD Million)
  • Table 93 Kuwait cancer cachexia market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Cancer cachexia market segmentation
  • Fig. 9 Market snapshot
  • Fig. 10 Therapeutic approach and disease outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Cancer cachexia market dynamics
  • Fig. 13 Cancer cachexia market: Porter's five forces analysis
  • Fig. 14 Cancer cachexia market: PESTLE analysis
  • Fig. 15 Treatment market, 2021 - 2033 (USD Million)
  • Fig. 16 Appetite stimulants market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Cannabinoid receptor agonists market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Corticosteroids market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Anabolic/androgenic agents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Type market, 2021 - 2033 (USD Million)
  • Fig. 22 Pancreatic cancer market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Gastric (stomach) cancer market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Lung cancer market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Colorectal cancer market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Distribution channel market, 2021 - 2033 (USD Million)
  • Fig. 28 Hospital pharmacies estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Retail pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 30 Online pharmacies estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Cancer cachexia market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 45 France country dynamics
  • Fig. 46 France cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark country dynamics
  • Fig. 56 Denmark cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 60 China country dynamics
  • Fig. 61 China cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 62 India country dynamics
  • Fig. 63 India cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 64 Australia country dynamics
  • Fig. 65 Australia cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea country dynamics
  • Fig. 67 South Korea cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 75 MEA cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait cancer cachexia market, 2021 - 2033 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework